nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—CYP19A1—Paclitaxel—kidney cancer	0.291	1	CbGbCtD
Nandrolone decanoate—Oligospermia—Gemcitabine—kidney cancer	0.0199	0.0478	CcSEcCtD
Nandrolone decanoate—Azoospermia—Gemcitabine—kidney cancer	0.0155	0.0372	CcSEcCtD
Nandrolone decanoate—Hoarseness—Sorafenib—kidney cancer	0.0123	0.0295	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Temsirolimus—kidney cancer	0.0116	0.0279	CcSEcCtD
Nandrolone decanoate—Hirsutism—Everolimus—kidney cancer	0.0107	0.0257	CcSEcCtD
Nandrolone decanoate—Hirsutism—Erlotinib—kidney cancer	0.0103	0.0248	CcSEcCtD
Nandrolone decanoate—Acne—Temsirolimus—kidney cancer	0.00992	0.0239	CcSEcCtD
Nandrolone decanoate—Dysphonia—Pazopanib—kidney cancer	0.00956	0.023	CcSEcCtD
Nandrolone decanoate—Oligospermia—Doxorubicin—kidney cancer	0.0088	0.0212	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Everolimus—kidney cancer	0.00862	0.0207	CcSEcCtD
Nandrolone decanoate—Fluid retention—Temsirolimus—kidney cancer	0.00793	0.0191	CcSEcCtD
Nandrolone decanoate—Hoarseness—Paclitaxel—kidney cancer	0.00792	0.0191	CcSEcCtD
Nandrolone decanoate—Acne—Everolimus—kidney cancer	0.00738	0.0178	CcSEcCtD
Nandrolone decanoate—Acne—Erlotinib—kidney cancer	0.00712	0.0171	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Everolimus—kidney cancer	0.00707	0.017	CcSEcCtD
Nandrolone decanoate—Azoospermia—Doxorubicin—kidney cancer	0.00684	0.0165	CcSEcCtD
Nandrolone decanoate—Dysphonia—Sorafenib—kidney cancer	0.00655	0.0158	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Pazopanib—kidney cancer	0.00653	0.0157	CcSEcCtD
Nandrolone decanoate—Hoarseness—Capecitabine—kidney cancer	0.0065	0.0156	CcSEcCtD
Nandrolone decanoate—Acne—Sunitinib—kidney cancer	0.00616	0.0148	CcSEcCtD
Nandrolone decanoate—Fluid retention—Everolimus—kidney cancer	0.0059	0.0142	CcSEcCtD
Nandrolone decanoate—Hirsutism—Capecitabine—kidney cancer	0.00492	0.0118	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Sorafenib—kidney cancer	0.00482	0.0116	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Sorafenib—kidney cancer	0.00448	0.0108	CcSEcCtD
Nandrolone decanoate—Furunculosis—Doxorubicin—kidney cancer	0.00434	0.0104	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Sunitinib—kidney cancer	0.00431	0.0104	CcSEcCtD
Nandrolone decanoate—Irritability—Everolimus—kidney cancer	0.0043	0.0104	CcSEcCtD
Nandrolone decanoate—Jaundice—Pazopanib—kidney cancer	0.00429	0.0103	CcSEcCtD
Nandrolone decanoate—Dysphonia—Paclitaxel—kidney cancer	0.00424	0.0102	CcSEcCtD
Nandrolone decanoate—Fluid retention—Gemcitabine—kidney cancer	0.00395	0.00951	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Temsirolimus—kidney cancer	0.00378	0.00909	CcSEcCtD
Nandrolone decanoate—Furuncle—Doxorubicin—kidney cancer	0.00376	0.00905	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Everolimus—kidney cancer	0.00359	0.00864	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Pazopanib—kidney cancer	0.00356	0.00857	CcSEcCtD
Nandrolone decanoate—Dysphonia—Capecitabine—kidney cancer	0.00348	0.00837	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Gemcitabine—kidney cancer	0.00346	0.00832	CcSEcCtD
Nandrolone decanoate—Jaundice—Everolimus—kidney cancer	0.00339	0.00815	CcSEcCtD
Nandrolone decanoate—Local reaction—Doxorubicin—kidney cancer	0.00333	0.00801	CcSEcCtD
Nandrolone decanoate—Fluid retention—Paclitaxel—kidney cancer	0.00331	0.00796	CcSEcCtD
Nandrolone decanoate—Hypertension—Temsirolimus—kidney cancer	0.00315	0.00758	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Sorafenib—kidney cancer	0.00311	0.0075	CcSEcCtD
Nandrolone decanoate—MAOB—nephron tubule—kidney cancer	0.00311	0.0761	CbGeAlD
Nandrolone decanoate—Oedema—Temsirolimus—kidney cancer	0.00298	0.00717	CcSEcCtD
Nandrolone decanoate—Hypertension—Pazopanib—kidney cancer	0.00297	0.00714	CcSEcCtD
Nandrolone decanoate—Jaundice—Sorafenib—kidney cancer	0.00294	0.00707	CcSEcCtD
Nandrolone decanoate—MAOB—renal system—kidney cancer	0.00283	0.0691	CbGeAlD
Nandrolone decanoate—Mediastinal disorder—Everolimus—kidney cancer	0.00281	0.00676	CcSEcCtD
Nandrolone decanoate—Oedema—Pazopanib—kidney cancer	0.00281	0.00675	CcSEcCtD
Nandrolone decanoate—MAOB—kidney—kidney cancer	0.00273	0.0668	CbGeAlD
Nandrolone decanoate—Fluid retention—Capecitabine—kidney cancer	0.00271	0.00653	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Erlotinib—kidney cancer	0.00271	0.00653	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Doxorubicin—kidney cancer	0.0027	0.00651	CcSEcCtD
Nandrolone decanoate—CYP19A1—gonad—kidney cancer	0.00269	0.0659	CbGeAlD
Nandrolone decanoate—MAOB—cortex of kidney—kidney cancer	0.00266	0.0651	CbGeAlD
Nandrolone decanoate—AR—renal system—kidney cancer	0.00266	0.065	CbGeAlD
Nandrolone decanoate—MAOA—nephron tubule—kidney cancer	0.00265	0.0649	CbGeAlD
Nandrolone decanoate—AR—kidney—kidney cancer	0.00257	0.0629	CbGeAlD
Nandrolone decanoate—Hyperlipidaemia—Doxorubicin—kidney cancer	0.00256	0.00615	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Vincristine—kidney cancer	0.00254	0.0061	CcSEcCtD
Nandrolone decanoate—MAOB—cardiac atrium—kidney cancer	0.00253	0.0619	CbGeAlD
Nandrolone decanoate—AR—cortex of kidney—kidney cancer	0.0025	0.0612	CbGeAlD
Nandrolone decanoate—Mediastinal disorder—Sorafenib—kidney cancer	0.00244	0.00587	CcSEcCtD
Nandrolone decanoate—MAOA—renal system—kidney cancer	0.00241	0.059	CbGeAlD
Nandrolone decanoate—AR—gonad—kidney cancer	0.00239	0.0583	CbGeAlD
Nandrolone decanoate—AR—cardiac atrium—kidney cancer	0.00238	0.0582	CbGeAlD
Nandrolone decanoate—Hepatic function abnormal—Capecitabine—kidney cancer	0.00238	0.00572	CcSEcCtD
Nandrolone decanoate—Hypertension—Vinblastine—kidney cancer	0.00235	0.00566	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Sunitinib—kidney cancer	0.00235	0.00565	CcSEcCtD
Nandrolone decanoate—Hypertension—Everolimus—kidney cancer	0.00234	0.00564	CcSEcCtD
Nandrolone decanoate—MAOA—kidney—kidney cancer	0.00233	0.057	CbGeAlD
Nandrolone decanoate—MAOA—cortex of kidney—kidney cancer	0.00227	0.0555	CbGeAlD
Nandrolone decanoate—Dysphonia—Doxorubicin—kidney cancer	0.00224	0.00539	CcSEcCtD
Nandrolone decanoate—Libido decreased—Capecitabine—kidney cancer	0.00224	0.00539	CcSEcCtD
Nandrolone decanoate—Oedema—Everolimus—kidney cancer	0.00222	0.00533	CcSEcCtD
Nandrolone decanoate—MAOA—cardiac atrium—kidney cancer	0.00216	0.0528	CbGeAlD
Nandrolone decanoate—Oedema—Erlotinib—kidney cancer	0.00214	0.00514	CcSEcCtD
Nandrolone decanoate—Pruritus—Temsirolimus—kidney cancer	0.00211	0.00507	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Doxorubicin—kidney cancer	0.0021	0.00505	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Capecitabine—kidney cancer	0.00206	0.00496	CcSEcCtD
Nandrolone decanoate—Hypertension—Sorafenib—kidney cancer	0.00203	0.0049	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Vincristine—kidney cancer	0.00199	0.00478	CcSEcCtD
Nandrolone decanoate—Pruritus—Pazopanib—kidney cancer	0.00199	0.00478	CcSEcCtD
Nandrolone decanoate—Irritability—Capecitabine—kidney cancer	0.00198	0.00477	CcSEcCtD
Nandrolone decanoate—Hypertension—Sunitinib—kidney cancer	0.00196	0.00471	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Gemcitabine—kidney cancer	0.00188	0.00453	CcSEcCtD
Nandrolone decanoate—Rash—Temsirolimus—kidney cancer	0.00188	0.00452	CcSEcCtD
Nandrolone decanoate—Dermatitis—Temsirolimus—kidney cancer	0.00188	0.00452	CcSEcCtD
Nandrolone decanoate—Oedema—Sunitinib—kidney cancer	0.00185	0.00445	CcSEcCtD
Nandrolone decanoate—Rash—Pazopanib—kidney cancer	0.00177	0.00426	CcSEcCtD
Nandrolone decanoate—Nausea—Temsirolimus—kidney cancer	0.00177	0.00426	CcSEcCtD
Nandrolone decanoate—Dermatitis—Pazopanib—kidney cancer	0.00177	0.00425	CcSEcCtD
Nandrolone decanoate—Oedema—Dactinomycin—kidney cancer	0.00175	0.00422	CcSEcCtD
Nandrolone decanoate—Fluid retention—Doxorubicin—kidney cancer	0.00175	0.00421	CcSEcCtD
Nandrolone decanoate—Nausea—Pazopanib—kidney cancer	0.00167	0.00401	CcSEcCtD
Nandrolone decanoate—Hypertension—Vincristine—kidney cancer	0.00166	0.00398	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Paclitaxel—kidney cancer	0.00158	0.0038	CcSEcCtD
Nandrolone decanoate—Hypertension—Gemcitabine—kidney cancer	0.00157	0.00378	CcSEcCtD
Nandrolone decanoate—Pruritus—Everolimus—kidney cancer	0.00157	0.00377	CcSEcCtD
Nandrolone decanoate—Oedema—Vincristine—kidney cancer	0.00157	0.00377	CcSEcCtD
Nandrolone decanoate—Jaundice—Capecitabine—kidney cancer	0.00156	0.00375	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Doxorubicin—kidney cancer	0.00153	0.00368	CcSEcCtD
Nandrolone decanoate—Urticaria—Sorafenib—kidney cancer	0.00153	0.00368	CcSEcCtD
Nandrolone decanoate—Pruritus—Erlotinib—kidney cancer	0.00151	0.00364	CcSEcCtD
Nandrolone decanoate—Oedema—Gemcitabine—kidney cancer	0.00148	0.00357	CcSEcCtD
Nandrolone decanoate—Rash—Everolimus—kidney cancer	0.0014	0.00336	CcSEcCtD
Nandrolone decanoate—Dermatitis—Everolimus—kidney cancer	0.0014	0.00336	CcSEcCtD
Nandrolone decanoate—Pruritus—Sorafenib—kidney cancer	0.00136	0.00327	CcSEcCtD
Nandrolone decanoate—Rash—Erlotinib—kidney cancer	0.00135	0.00324	CcSEcCtD
Nandrolone decanoate—Dermatitis—Erlotinib—kidney cancer	0.00135	0.00324	CcSEcCtD
Nandrolone decanoate—Nausea—Vinblastine—kidney cancer	0.00132	0.00318	CcSEcCtD
Nandrolone decanoate—Nausea—Everolimus—kidney cancer	0.00132	0.00317	CcSEcCtD
Nandrolone decanoate—Hypertension—Paclitaxel—kidney cancer	0.00132	0.00317	CcSEcCtD
Nandrolone decanoate—Pruritus—Sunitinib—kidney cancer	0.00131	0.00315	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Capecitabine—kidney cancer	0.00129	0.00311	CcSEcCtD
Nandrolone decanoate—Nausea—Erlotinib—kidney cancer	0.00127	0.00306	CcSEcCtD
Nandrolone decanoate—Oedema—Paclitaxel—kidney cancer	0.00124	0.00299	CcSEcCtD
Nandrolone decanoate—Rash—Sorafenib—kidney cancer	0.00121	0.00292	CcSEcCtD
Nandrolone decanoate—Dermatitis—Sorafenib—kidney cancer	0.00121	0.00292	CcSEcCtD
Nandrolone decanoate—Rash—Sunitinib—kidney cancer	0.00117	0.00281	CcSEcCtD
Nandrolone decanoate—Dermatitis—Sunitinib—kidney cancer	0.00117	0.00281	CcSEcCtD
Nandrolone decanoate—Nausea—Sorafenib—kidney cancer	0.00114	0.00275	CcSEcCtD
Nandrolone decanoate—Rash—Dactinomycin—kidney cancer	0.0011	0.00266	CcSEcCtD
Nandrolone decanoate—Nausea—Sunitinib—kidney cancer	0.0011	0.00265	CcSEcCtD
Nandrolone decanoate—Hypertension—Capecitabine—kidney cancer	0.00108	0.0026	CcSEcCtD
Nandrolone decanoate—Pruritus—Gemcitabine—kidney cancer	0.00105	0.00253	CcSEcCtD
Nandrolone decanoate—Nausea—Dactinomycin—kidney cancer	0.00104	0.0025	CcSEcCtD
Nandrolone decanoate—Oedema—Capecitabine—kidney cancer	0.00102	0.00246	CcSEcCtD
Nandrolone decanoate—Jaundice—Doxorubicin—kidney cancer	0.00101	0.00242	CcSEcCtD
Nandrolone decanoate—Urticaria—Paclitaxel—kidney cancer	0.000988	0.00238	CcSEcCtD
Nandrolone decanoate—Rash—Vincristine—kidney cancer	0.000987	0.00238	CcSEcCtD
Nandrolone decanoate—Dermatitis—Vincristine—kidney cancer	0.000986	0.00237	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—JUN—kidney cancer	0.000951	0.00377	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—CDKN1B—kidney cancer	0.000948	0.00375	CbGpPWpGaD
Nandrolone decanoate—Rash—Gemcitabine—kidney cancer	0.000936	0.00225	CcSEcCtD
Nandrolone decanoate—Dermatitis—Gemcitabine—kidney cancer	0.000935	0.00225	CcSEcCtD
Nandrolone decanoate—Nausea—Vincristine—kidney cancer	0.00093	0.00224	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000907	0.00359	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—PAK1—kidney cancer	0.000904	0.00358	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000888	0.00352	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—GSTM1—kidney cancer	0.000884	0.0035	CbGpPWpGaD
Nandrolone decanoate—Nausea—Gemcitabine—kidney cancer	0.000882	0.00212	CcSEcCtD
Nandrolone decanoate—Pruritus—Paclitaxel—kidney cancer	0.00088	0.00212	CcSEcCtD
Nandrolone decanoate—MAOA—Biological oxidations—GSTT1—kidney cancer	0.000871	0.00345	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CDKN2A—kidney cancer	0.000869	0.00344	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—ANXA1—kidney cancer	0.000866	0.00343	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TSC1—kidney cancer	0.000866	0.00343	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—kidney cancer	0.000861	0.00341	CbGpPWpGaD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—PIK3CA—kidney cancer	0.000859	0.0034	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTT1—kidney cancer	0.000849	0.00336	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—AURKA—kidney cancer	0.000842	0.00334	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—CYP1A1—kidney cancer	0.000838	0.00332	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Doxorubicin—kidney cancer	0.000834	0.00201	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000834	0.0033	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000823	0.00326	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—JUN—kidney cancer	0.000819	0.00324	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—PTGS1—kidney cancer	0.000816	0.00323	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Capecitabine—kidney cancer	0.00081	0.00195	CcSEcCtD
Nandrolone decanoate—MAOA—Neuronal System—KCNMA1—kidney cancer	0.000799	0.00317	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—PTGS1—kidney cancer	0.000796	0.00315	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—kidney cancer	0.000792	0.00314	CbGpPWpGaD
Nandrolone decanoate—Rash—Paclitaxel—kidney cancer	0.000784	0.00189	CcSEcCtD
Nandrolone decanoate—Dermatitis—Paclitaxel—kidney cancer	0.000783	0.00188	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—PAK1—kidney cancer	0.000777	0.00308	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000772	0.00306	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000749	0.00296	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000749	0.00296	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BRCA2—kidney cancer	0.000742	0.00294	CbGpPWpGaD
Nandrolone decanoate—Nausea—Paclitaxel—kidney cancer	0.000738	0.00178	CcSEcCtD
Nandrolone decanoate—MAOA—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000738	0.00292	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ACY1—kidney cancer	0.000737	0.00292	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CCND1—kidney cancer	0.000734	0.00291	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CTNNB1—kidney cancer	0.000727	0.00288	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000726	0.00288	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Capecitabine—kidney cancer	0.000722	0.00174	CcSEcCtD
Nandrolone decanoate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.00072	0.00285	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000702	0.00278	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.0007	0.00277	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—kidney cancer	0.000699	0.00277	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Doxorubicin—kidney cancer	0.000696	0.00167	CcSEcCtD
Nandrolone decanoate—AR—Gene Expression—HARS—kidney cancer	0.000674	0.00267	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000672	0.00266	CbGpPWpGaD
Nandrolone decanoate—Oedema—Doxorubicin—kidney cancer	0.000658	0.00158	CcSEcCtD
Nandrolone decanoate—Rash—Capecitabine—kidney cancer	0.000643	0.00155	CcSEcCtD
Nandrolone decanoate—Dermatitis—Capecitabine—kidney cancer	0.000643	0.00155	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—kidney cancer	0.000638	0.00253	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PDHB—kidney cancer	0.000627	0.00248	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—POMC—kidney cancer	0.000625	0.00247	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—RELA—kidney cancer	0.000618	0.00245	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000615	0.00243	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000609	0.00241	CbGpPWpGaD
Nandrolone decanoate—Nausea—Capecitabine—kidney cancer	0.000606	0.00146	CcSEcCtD
Nandrolone decanoate—MAOA—Biological oxidations—GSTP1—kidney cancer	0.000603	0.00239	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000595	0.00236	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—ACHE—kidney cancer	0.000591	0.00234	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—kidney cancer	0.000591	0.00234	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—kidney cancer	0.000589	0.00233	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CCBL1—kidney cancer	0.000589	0.00233	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTP1—kidney cancer	0.000589	0.00233	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TSC2—kidney cancer	0.000587	0.00232	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—kidney cancer	0.000585	0.00232	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	0.000584	0.00231	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—GSTP1—kidney cancer	0.00058	0.0023	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—EIF5B—kidney cancer	0.000573	0.00227	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000573	0.00227	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—GSTM1—kidney cancer	0.000555	0.0022	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CCND1—kidney cancer	0.000542	0.00215	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—JUN—kidney cancer	0.000541	0.00214	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTM1—kidney cancer	0.000541	0.00214	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CTNNB1—kidney cancer	0.000537	0.00213	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—GSTM1—kidney cancer	0.000533	0.00211	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—CYP1A1—kidney cancer	0.000526	0.00208	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—PTEN—kidney cancer	0.000524	0.00207	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Doxorubicin—kidney cancer	0.000522	0.00126	CcSEcCtD
Nandrolone decanoate—MAOA—Neuronal System—BCHE—kidney cancer	0.000515	0.00204	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—CYP1A1—kidney cancer	0.000513	0.00203	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PPAT—kidney cancer	0.000511	0.00202	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GLIPR1—kidney cancer	0.000511	0.00202	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP1A1—kidney cancer	0.000506	0.002	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000505	0.002	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TSC2—kidney cancer	0.000505	0.002	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BRAF—kidney cancer	0.000487	0.00193	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CDH1—kidney cancer	0.000477	0.00189	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—FH—kidney cancer	0.000475	0.00188	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—APRT—kidney cancer	0.000475	0.00188	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—kidney cancer	0.000474	0.00188	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	0.000469	0.00186	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Doxorubicin—kidney cancer	0.000465	0.00112	CcSEcCtD
Nandrolone decanoate—MAOA—Metabolism—ACY1—kidney cancer	0.000462	0.00183	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ACY1—kidney cancer	0.000451	0.00179	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GPC3—kidney cancer	0.000446	0.00177	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CA2—kidney cancer	0.000434	0.00172	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000429	0.0017	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ALAD—kidney cancer	0.000423	0.00168	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—kidney cancer	0.000419	0.00166	CbGpPWpGaD
Nandrolone decanoate—Rash—Doxorubicin—kidney cancer	0.000415	0.000998	CcSEcCtD
Nandrolone decanoate—Dermatitis—Doxorubicin—kidney cancer	0.000414	0.000997	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—ST3GAL2—kidney cancer	0.000413	0.00164	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—kidney cancer	0.00041	0.00162	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ALDH1A1—kidney cancer	0.000404	0.0016	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.000397	0.00157	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PDHB—kidney cancer	0.000393	0.00156	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—POMC—kidney cancer	0.000392	0.00155	CbGpPWpGaD
Nandrolone decanoate—Nausea—Doxorubicin—kidney cancer	0.000391	0.00094	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—PGK1—kidney cancer	0.000387	0.00153	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC5A3—kidney cancer	0.000387	0.00153	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000385	0.00152	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PDHB—kidney cancer	0.000383	0.00152	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—POMC—kidney cancer	0.000382	0.00151	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—LDHB—kidney cancer	0.00038	0.0015	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—JUNB—kidney cancer	0.000372	0.00147	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CCBL1—kidney cancer	0.00037	0.00146	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—EEF2—kidney cancer	0.000369	0.00146	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CCBL1—kidney cancer	0.000361	0.00143	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CCND1—kidney cancer	0.000355	0.00141	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—JUN—kidney cancer	0.000355	0.0014	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—TET2—kidney cancer	0.000354	0.0014	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	0.000352	0.00139	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000345	0.00137	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000343	0.00136	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000343	0.00136	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000343	0.00136	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.000342	0.00135	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000337	0.00133	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000333	0.00132	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CA9—kidney cancer	0.000329	0.0013	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000326	0.00129	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000326	0.00129	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—TCEB1—kidney cancer	0.000324	0.00128	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—TCEB2—kidney cancer	0.000324	0.00128	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PPAT—kidney cancer	0.000321	0.00127	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GLIPR1—kidney cancer	0.000321	0.00127	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GLIPR1—kidney cancer	0.000313	0.00124	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PPAT—kidney cancer	0.000313	0.00124	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	0.00031	0.00123	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000309	0.00122	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000309	0.00122	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—kidney cancer	0.000306	0.00121	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000306	0.00121	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—JUN—kidney cancer	0.000305	0.00121	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000305	0.00121	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	0.000303	0.0012	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000303	0.0012	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000302	0.0012	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000302	0.0012	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—APRT—kidney cancer	0.000298	0.00118	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—FH—kidney cancer	0.000298	0.00118	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000295	0.00117	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000294	0.00117	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000294	0.00116	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000292	0.00115	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—APRT—kidney cancer	0.000291	0.00115	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—FH—kidney cancer	0.000291	0.00115	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000286	0.00113	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MYC—kidney cancer	0.000285	0.00113	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000284	0.00113	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000284	0.00112	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GPC3—kidney cancer	0.00028	0.00111	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CRABP1—kidney cancer	0.00028	0.00111	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	0.000279	0.0011	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GPC3—kidney cancer	0.000273	0.00108	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CA2—kidney cancer	0.000273	0.00108	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	0.000267	0.00106	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000266	0.00105	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CA2—kidney cancer	0.000266	0.00105	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ALAD—kidney cancer	0.000266	0.00105	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—KRAS—kidney cancer	0.000263	0.00104	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—RPL14—kidney cancer	0.000263	0.00104	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—BRAF—kidney cancer	0.000263	0.00104	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ITPR2—kidney cancer	0.00026	0.00103	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ST3GAL2—kidney cancer	0.000259	0.00103	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ALAD—kidney cancer	0.000259	0.00103	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000257	0.00102	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ALDH1A1—kidney cancer	0.000253	0.001	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ST3GAL2—kidney cancer	0.000253	0.001	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ALDH1A1—kidney cancer	0.000247	0.000979	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MYC—kidney cancer	0.000245	0.000971	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PGK1—kidney cancer	0.000243	0.000962	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC5A3—kidney cancer	0.000243	0.000962	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000243	0.000962	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	0.00024	0.00095	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—LDHB—kidney cancer	0.000238	0.000943	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ACHE—kidney cancer	0.000237	0.00094	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTT1—kidney cancer	0.000237	0.00094	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PGK1—kidney cancer	0.000237	0.000938	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC5A3—kidney cancer	0.000237	0.000938	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000236	0.000935	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—kidney cancer	0.000234	0.000927	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—LDHB—kidney cancer	0.000232	0.00092	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000231	0.000915	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	0.000227	0.000897	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SCARB1—kidney cancer	0.000225	0.000889	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS1—kidney cancer	0.000222	0.00088	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—RAF1—kidney cancer	0.000219	0.000869	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000218	0.000864	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PSMD7—kidney cancer	0.000218	0.000863	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—EIF4EBP1—kidney cancer	0.000215	0.00085	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—HSPB1—kidney cancer	0.000215	0.00085	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—BCHE—kidney cancer	0.000207	0.000819	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CA9—kidney cancer	0.000207	0.000818	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC5A5—kidney cancer	0.000204	0.000809	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CA9—kidney cancer	0.000201	0.000798	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—kidney cancer	0.000201	0.000798	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.0002	0.000794	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PSMD7—kidney cancer	0.000199	0.00079	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC2A1—kidney cancer	0.000197	0.000781	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000197	0.00078	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000196	0.000778	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000194	0.000768	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—JUNB—kidney cancer	0.000179	0.000709	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CRABP1—kidney cancer	0.000176	0.000695	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CRABP1—kidney cancer	0.000171	0.000678	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTP1—kidney cancer	0.000164	0.000651	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ITPR2—kidney cancer	0.000163	0.000647	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ITPR2—kidney cancer	0.000159	0.000631	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ABCB1—kidney cancer	0.000156	0.000616	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTM1—kidney cancer	0.000151	0.000598	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—MAPK1—kidney cancer	0.000151	0.000596	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ACHE—kidney cancer	0.000149	0.00059	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTT1—kidney cancer	0.000149	0.00059	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000147	0.000581	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—CDKN2B—kidney cancer	0.000146	0.000577	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTT1—kidney cancer	0.000145	0.000575	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ACHE—kidney cancer	0.000145	0.000575	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP1A1—kidney cancer	0.000143	0.000567	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SCARB1—kidney cancer	0.000141	0.000558	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS1—kidney cancer	0.00014	0.000552	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SCARB1—kidney cancer	0.000137	0.000544	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PSMD7—kidney cancer	0.000137	0.000542	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS1—kidney cancer	0.000136	0.000539	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PSMD7—kidney cancer	0.000133	0.000528	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—BCHE—kidney cancer	0.00013	0.000514	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC5A5—kidney cancer	0.000128	0.000507	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—BCHE—kidney cancer	0.000127	0.000501	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC5A5—kidney cancer	0.000125	0.000495	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC2A1—kidney cancer	0.000124	0.00049	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC2A1—kidney cancer	0.000121	0.000478	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—MYC—kidney cancer	0.000117	0.000465	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000117	0.000464	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—POMC—kidney cancer	0.000107	0.000423	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTP1—kidney cancer	0.000103	0.000409	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000102	0.000404	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTP1—kidney cancer	0.000101	0.000399	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ABCB1—kidney cancer	9.77e-05	0.000387	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ABCB1—kidney cancer	9.53e-05	0.000377	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTM1—kidney cancer	9.48e-05	0.000376	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTM1—kidney cancer	9.25e-05	0.000366	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP1A1—kidney cancer	8.99e-05	0.000356	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP1A1—kidney cancer	8.77e-05	0.000347	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS2—kidney cancer	8.52e-05	0.000337	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTEN—kidney cancer	7.43e-05	0.000294	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.2e-05	0.000285	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—POMC—kidney cancer	6.7e-05	0.000265	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—POMC—kidney cancer	6.54e-05	0.000259	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MAPK3—kidney cancer	5.81e-05	0.00023	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MYC—kidney cancer	5.65e-05	0.000224	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS2—kidney cancer	5.35e-05	0.000212	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CA—kidney cancer	5.24e-05	0.000208	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS2—kidney cancer	5.21e-05	0.000206	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTEN—kidney cancer	4.66e-05	0.000185	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTEN—kidney cancer	4.55e-05	0.00018	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CA—kidney cancer	3.29e-05	0.00013	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CA—kidney cancer	3.21e-05	0.000127	CbGpPWpGaD
